A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea
Public ClinicalTrials.gov record NCT03276936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 for 40 Weeks in the Treatment of Moderate to Severe Facial Papulopustular Rosacea (Study FX2016-13)
Study identification
- NCT ID
- NCT03276936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vyne Therapeutics Inc.
- Industry
- Enrollment
- 504 participants
Conditions and interventions
Conditions
Interventions
- FMX103 1.5% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 4, 2017
- Primary completion
- Jan 2, 2019
- Completion
- Jan 14, 2019
- Last update posted
- Jan 17, 2022
2017 – 2019
United States locations
- U.S. sites
- 79
- U.S. states
- 28
- U.S. cities
- 75
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Foamix Investigational Site # 207 | Glendale | Arizona | 85308 | — |
| Foamix Investigational Site # 202 | Hot Springs | Arkansas | 71913 | — |
| Foamix Investigational Site # 222 | Rogers | Arkansas | 72758 | — |
| Foamix Investigational Site # 127 | Fremont | California | 94538 | — |
| Foamix Investigational Site # 226 | Los Angeles | California | 90045 | — |
| Foamix Investigational Site # 220 | Murrieta | California | 92562 | — |
| Foamix Investigational Site # 131 | Oceanside | California | 92056 | — |
| Foamix Investigational Site # 134 | Sacramento | California | 95819 | — |
| Foamix Investigational Site # 114 | San Diego | California | 92123 | — |
| Foamix Investigational Site # 116 | San Luis Obispo | California | 93405 | — |
| Foamix Investigational Site # 135 | Santa Ana | California | 92705 | — |
| Foamix Investigational Site # 123 | Santa Monica | California | 90403 | — |
| Foamix Investigational Site # 239 | Temecula | California | 92592 | — |
| Foamix Investigational Site # 227 | Denver | Colorado | 80209 | — |
| Foamix Investigational Site # 223 | Boca Raton | Florida | 33486 | — |
| Foamix Investigational Site # 215 | Boynton Beach | Florida | 33437 | — |
| Foamix Investigational Site # 109 | Clearwater | Florida | 33757 | — |
| Foamix Investigational Site # 240 | Fort Myers | Florida | 33912 | — |
| Foamix Investigational Site # 112 | Hialeah | Florida | 33016 | — |
| Foamix Investigational Site # 214 | Miami | Florida | 33126 | — |
| Foamix Investigational Site # 241 | North Miami Beach | Florida | 33162 | — |
| Foamix Investigational Site # 104 | Ormond Beach | Florida | 32174 | — |
| Foamix Investigational Site # 121 | Sanford | Florida | 32771 | — |
| Foamix Investigational Site # 125 | Tampa | Florida | 33609 | — |
| Foamix Investigational Site # 124 | West Palm Beach | Florida | 33409 | — |
| Foamix Investigational Site # 118 | Alpharetta | Georgia | 30022 | — |
| Foamix Investigational Site # 204 | Newnan | Georgia | 78660 | — |
| Foamix Investigational Site # 233 | Sandy Springs | Georgia | 30328 | — |
| Foamix Investigational Site # 139 | Snellville | Georgia | 30078 | — |
| Foamix Investigational Site # 211 | Arlington Heights | Illinois | 60005 | — |
| Foamix Investigational Site # 138 | New Albany | Indiana | 47150 | — |
| Foamix Investigational Site # 225 | Newburgh | Indiana | 47630 | — |
| Foamix Investigational Site # 218 | South Bend | Indiana | 46617 | — |
| Foamix Investigational Site # 235 | Louisville | Kentucky | 40217 | — |
| Foamix Investigational Site # 237 | Louisville | Kentucky | 40241 | — |
| Foamix Investigational Site # 102 | Metairie | Louisiana | 70006 | — |
| Foamix Investigational Site # 115 | New Orleans | Louisiana | 70115 | — |
| Foamix Investigational Site # 110 | Beverly | Massachusetts | 01915 | — |
| Foamix Investigational Site # 107 | Brighton | Massachusetts | 02135 | — |
| Foamix Investigational Site # 229 | Watertown | Massachusetts | 02472 | — |
| Foamix Investigational Site # 137 | Ann Arbor | Michigan | 48103 | — |
| Foamix Investigational Site # 242 | Bay City | Michigan | 48706 | — |
| Foamix Investigational Site # 210 | Detroit | Michigan | 48202 | — |
| Foamix Investigational Site # 103 | Fort Gratiot | Michigan | 48059 | — |
| Foamix Investigational Site # 120 | Troy | Michigan | 48084 | — |
| Foamix Investigational Site # 140 | Warren | Michigan | 48088 | — |
| Foamix Investigational Site # 232 | Fridley | Minnesota | 55432 | — |
| Foamix Investigational Site # 130 | Saint Joseph | Missouri | 64506 | — |
| Foamix Investigational Site # 133 | Omaha | Nebraska | 68144 | — |
| Foamix Investigational Site # 221 | Las Vegas | Nevada | 89128 | — |
| Foamix Investigational Site # 136 | New York | New York | 10075 | — |
| Foamix Investigational Site # 111 | Stony Brook | New York | 11790 | — |
| Foamix Investigational Site # 119 | Charlotte | North Carolina | 28277 | — |
| Foamix Investigational Site # 238 | High Point | North Carolina | 27262 | — |
| Foamix Investigational Site # 212 | Raleigh | North Carolina | 27612 | — |
| Foamix Investigational Site # 234 | Winston-Salem | North Carolina | 27103 | — |
| Foamix Investigational Site # 101 | Bexley | Ohio | 43209 | — |
| Foamix Investigational Site # 128 | Dublin | Ohio | 43016 | — |
| Foamix Investigational Site # 236 | Norman | Oklahoma | 73071 | — |
| Foamix Investigational Site # 224 | Exton | Pennsylvania | 19341 | — |
| Foamix Investigational Site # 141 | Jenkintown | Pennsylvania | 19046 | — |
| Foamix Investigational Site # 129 | Yardley | Pennsylvania | 19067 | — |
| Foamix Investigational Site # 105 | Johnston | Rhode Island | 02919 | — |
| Foamix Investigational Site # 231 | Charleston | South Carolina | 29407 | — |
| Foamix Investigational Site # 106 | Greenville | South Carolina | 29607 | — |
| Foamix Investigational Site # 230 | Mt. Pleasant | South Carolina | 29464 | — |
| Foamix Investigational Site # 228 | Knoxville | Tennessee | 37922 | — |
| Foamix Investigational Site # 219 | Arlington | Texas | 76011 | — |
| Foamix Investigational Site # 132 | Austin | Texas | 78746 | — |
| Foamix Investigational Site # 117 | Austin | Texas | 78759 | — |
| Foamix Investigational Site # 201 | Houston | Texas | 77004 | — |
| Foamix Investigational Site # 206 | Pflugerville | Texas | 78660 | — |
| Foamix Investigational Site # 108 | San Antonio | Texas | 78213 | — |
| Foamix Investigational Site # 208 | San Antonio | Texas | 78229 | — |
| Foamix Investigational Site # 213 | San Antonio | Texas | 78229 | — |
| Foamix Investigational Site # 209 | Webster | Texas | 77598 | — |
| Foamix Investigational Site # 126 | Salt Lake City | Utah | 84117 | — |
| Foamix Investigational Site # 216 | Lynchburg | Virginia | 24501 | — |
| Foamix Investigational Site # 203 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03276936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03276936 live on ClinicalTrials.gov.